Ixensor Co

Ixensor Co Stock-Based Compensation

The Stock-Based Compensation (SBC) of Ixensor Co (6734.TWO) as of Nov 5, 2026 is 24,000.00 TWD. In the previous year, Stock-Based Compensation (SBC) was 17,000.00 TWD — a change of 41.18% (higher).

Stock-Based Compensation

24,000.00TWD

YoY

41.18%

Last updated:

Stock-Based Compensation (SBC) of Ixensor Co is 2025 24,000.00 TWD. Stock-Based Compensation (SBC) of Ixensor Co was 2024 17,000.00 TWD. It decreases by 41.18% higher compared to the previous year.

The Ixensor Co Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2019
2.70 M TWD
Jan 1, 2020
170,000.00 TWD
Jan 1, 2021
669,000.00 TWD
Jan 1, 2022
93,000.00 TWD
Jan 1, 2023
245,000.00 TWD
Jan 1, 2024
17,000.00 TWD
Jan 1, 2025
24,000.00 TWD
The Ixensor Co Stock-Based Compensation history
YEARStock-Based CompensationYoY
24,000.00TWD+41.18%
17,000.00TWD-93.06%
245,000.00TWD+163.44%
93,000.00TWD-86.10%
669,000.00TWD+293.53%
170,000.00TWD-93.70%
2.70 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ixensor Co Stock analysis

What does Ixensor Co do? iXensor Co., Ltd. generates revenue through its PixoTest Blood Glucose Monitoring System and ovulation detection system, targeting individuals managing diabetes and reproductive health. The company's technology platform measures biochemical parameters including blood sugar, luteinizing hormone, and cholesterol, providing data for diabetes management services. Its integrated medical device solutions serve customers seeking self-monitoring tools for chronic conditions and fertility tracking. The firm's products are designed for direct consumer use, with the PixoTest system offering blood glucose monitoring and the ovulation detection system supporting female hormone cycle management. These solutions leverage the company's platform to deliver personalized health insights without requiring third-party partnerships. The target segments include patients with diabetes and individuals tracking fertility cycles through biochemical monitoring. Ixensor Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ixensor Co stock

Stock-Based Compensation (SBC) of Ixensor Co is 24,000.00 TWD in 2025.

Stock-Based Compensation (SBC) of Ixensor Co changed from 17,000.00 TWD to 24,000.00 TWD, representing a 41.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Ixensor Co since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Ixensor Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ixensor Co

All Key Metrics — Ixensor Co